Breaking News Instant updates and real-time market news.

CI

Cigna

$187.06

1.95 (1.05%)

, IBM

IBM

$137.18

1.09 (0.80%)

11:34
02/13/19
02/13
11:34
02/13/19
11:34

Cigna, Sentara Healthcare expand blockchain-based ecosystem for healthcare

IBM (IBM) announced that Cigna (CI) and Sentara Healthcare have joined a new health utility network using blockchain. The aim of the network is to convene a broad ecosystem of healthcare organizations in a highly secure, shared environment with the goal of enabling organizations to build, share and deploy solutions using blockchain that drive digital transformation in the industry. The network also includes Aetna, Anthem, Health Care Service Corporation, and PNC Bank. Together they are exploring ways that blockchain can be used to address a range of industry challenges, including promoting efficient claims and payment processing, enabling secure and frictionless healthcare information exchanges, and ways to maintain current and accurate provider directories.

CI

Cigna

$187.06

1.95 (1.05%)

IBM

IBM

$137.18

1.09 (0.80%)

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

CI Cigna
$187.06

1.95 (1.05%)

01/16/19
MSCO
01/16/19
NO CHANGE
MSCO
Morgan Stanley says UnitedHealth, Walgreens could benefit from CVS-Walmart fight
After CVS Health (CVS) announced Walmart (WMT) will leave Caremark's commercial and Managed Medicaid retail pharmacy networks at the end of April 2019, analysts at Morgan Stanley discussed the potential impact of the fight to both companies and to competitors. Analyst Ricky Goldwasser said the dispute "brings back memories" of the Express Scripts (ESRX) and Walgreens (WBA) breakup in 2011, but unlike in that case it is only the early days of the 2019/2020 selling season, not after the selling season concluded. Walmart's plans to leave should have a limited impact on CVS' FY19 EPS power, but adds uncertainty to PBM selling season if not resolved in the near-term, said Goldwasser. Morgan Stanley's Simeon Gutman said that if the dispute is not resolved, it could end up reducing Walmart's EBIT by about $260M in 2019, which he estimates could have a 7c, or 1.5%, impact on EPS. In terms of who may benefit if no resolution is reached, the team estimates both Walgreens and CVS retail could gain an incremental 25 bps of pharmacy share and that UnitedHealth's (UNH) Optum and Cigna (CI) could see a step up in PBM selling season win rates. However, given Walmart's relatively low share, they view the PBM share opportunity as "minimal."
01/31/19
MSCO
01/31/19
NO CHANGE
Target $391
MSCO
Overweight
Anthem price target raised to $391 from $372 at Morgan Stanley
Morgan Stanley analyst Zack Sopcak said Anthem's (ANTM) launch of IngenioRx three quarters early, giving it a presence in the 2020 selling season, leads him to see an increased likelihood of gaining share as compared to entry in the 2021 selling season when CVS Health (CVS) and Cigna (CI) would have more time for their marketing messages to mature post their respective mergers. While also noting that Anthem's 2019 guidance for EPS of $19+ came in well above estimates, Sopcak raised his price target on the stock to $391 from $372 and reiterated as a top pick with an Overweight rating.
02/01/19
GSCO
02/01/19
NO CHANGE
GSCO
Conviction Buy
Cigna provided 'much needed clarity' on earnings call, says Goldman Sachs
Goldman Sachs analyst Stephen Tanal said Cigna's "extensive details" on its Q4 earnings call provided "much needed visibility" and clarity and boosted his confidence. Rebate guarantees are not expected to be a headwind in 2019 and the company does not expect the proposed rule from HHS to remove the safe harbor for rebates to have a meaningful impact on growth or its earnings trajectory, Tanal tells investors. He reiterates a Buy rating on Cigna shares and keeps it on the firm's Conviction List.
02/04/19
PIPR
02/04/19
NO CHANGE
Target $227
PIPR
Overweight
Piper Jaffray likes the set-up for Cigna shares in 2019
Piper Jaffray analyst Sarah James likes the set-up for Cigna (CI) in 2019. The company has built 25c-50c of conservatism into its earnings guidance and has potential for a "strong" 2020 driven by better cost trend control, its specialty business, and working down the $200M stranded overhead cost from Anthem's departure, James tells investors in a research note. Further, the analyst does not have the pharmacy benefits manager volume coming back in-house from UnitedHealth (UNH) in her numbers yet, which she sees as "likely upside to 2021." The analyst also believes Cigna "screens as cheap" at 10.6 times expected 2020 earnings. James reiterates an Overweight rating on the shares with a $227 price target.
IBM IBM
$137.18

1.09 (0.80%)

01/23/19
WELS
01/23/19
NO CHANGE
Target $140
WELS
Market Perform
IBM price target lowered to $140 from $155 at Wells Fargo
Wells Fargo analyst Ed Caso lowered his price target for IBM to $140 from $155 to reflect a lower market multiple and the lack of 2020-2021 share repurchase expected, offset by signs of further progress in its digital transition. The analyst reiterates a Market Perform rating on the shares.
01/23/19
BMOC
01/23/19
NO CHANGE
Target $147
BMOC
Market Perform
IBM price target raised to $147 from $145 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on IBM (IBM) to $147 after the company's better than expected Q4 revenues in its "three important business units of Cognitive, GBS and Tech Services." The analyst also contends that while the outlook for FY19 earnings was below consensus, he sees progress on revenues as more important for the company. Bachman adds that he remains constructive on the impact of IBM's pending Red Hat (RHT) deal improving its top line, but does not see the current valuation for IBM as sufficiently compelling for a more constructive view, keeping his Market Perform rating.
01/31/19
TIGR
01/31/19
NO CHANGE
TIGR
Neutral
IBM's Cognitive Solutions strength offset by weak System, says Tigress Financial
Tigress Financial analyst Ivan Feinseth kept his Hold rating on IBM after another set of mixed results reported for Q4 last week. The analyst notes that the company's strong Cognitive Solutions performance continues to be offset by ongoing weakness in Systems revenue. Feinseth adds that its Business Performance is also trending, but sees IBM "starting to benefit from the growing performance of its Cognitive Solutions and Global Business Services business lines", driven by "growing demand for analytics, IoT, and security services."
02/11/19
PIPR
02/11/19
NO CHANGE
PIPR
Piper storage survey positive for Pure Storage, Nutanix, NetApp
Piper Jaffray conducted its fiscal Q4 Storage Reseller Survey by collecting feedback from 28 resellers and distributors. While only five of 14 vendors had net positive results versus six of the 14 last quarter, the firm saw "strong results" for Pure Storage (PSTG), Rubrik, Nutanix (NTNX), Veeam and NetApp (NTAP), analyst Andrew Nowinski told investors earlier in a research note. Pure Storage also had the strongest pipeline heading into the April quarter, added the analyst. The company's results sharply improved in the survey, with 67% of resellers citing "Above Plan" results, the highest level seen in three years, says Nowinski. The stock in early trading is up 19c to $18.47. Of those surveyed by Piper, 36% of resellers said they saw a negative impact from the U.S. government shutdown, with Dell (DELL), HP/3PAR (HPQ) and IBM (IMB) the most impacted.

TODAY'S FREE FLY STORIES

LBY

Libbey

$5.75

0.15 (2.68%)

18:14
02/20/19
02/20
18:14
02/20/19
18:14
Earnings
Libbey sees FY19 revenue increase in low single digits, one estimate $806.6M »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LBY

Libbey

$5.75

0.15 (2.68%)

18:13
02/20/19
02/20
18:13
02/20/19
18:13
Earnings
Libbey reports Q4 EPS (18c), two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:07
02/20/19
02/20
18:07
02/20/19
18:07
Hot Stocks
NetEase reports Q4 online game service revenues up 37.7% at $1.6B »

Reports Q4 e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:05
02/20/19
02/20
18:05
02/20/19
18:05
Hot Stocks
NetEase declares Q4 quarterly dividend of 48c vs 45c in Q3 »

The dividend is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Earnings
NetEase reports Q4 EPS $2.66, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LEE

Lee Enterprises

$2.61

0.01 (0.38%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Hot Stocks
Lee Enterprises board approves $10M stock repurchase program »

Lee Enterprises announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNY

Kearny Financial

$13.48

-0.01 (-0.07%)

18:03
02/20/19
02/20
18:03
02/20/19
18:03
Hot Stocks
Kearny Financial raises quarterly dividend to 6c per share from 5c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Earnings
Breaking Earnings news story on Copart »

Copart reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

CE

Celanese

$102.65

1.71 (1.69%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Hot Stocks
Celanese raises Acetyl Intermediates price by 5c per lb »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:01
02/20/19
02/20
18:01
02/20/19
18:01
Earnings
Copart reports Q2 EPS 55c, consensus 51c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

WPG

Washington Prime

$5.77

(0.00%)

17:50
02/20/19
02/20
17:50
02/20/19
17:50
Earnings
Breaking Earnings news story on Washington Prime »

Washington Prime sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CPA

Copa Holdings

$89.89

-0.8 (-0.88%)

, GE

General Electric

$10.10

-0.03 (-0.30%)

17:49
02/20/19
02/20
17:49
02/20/19
17:49
Hot Stocks
Copa Airlines picks GE Aviation for digital records management »

Copa Airlines (CPA) has…

CPA

Copa Holdings

$89.89

-0.8 (-0.88%)

GE

General Electric

$10.10

-0.03 (-0.30%)

BA

Boeing

$421.61

5.21 (1.25%)

ERJ

Embraer

$20.52

-0.14 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 11

    Mar

  • 12

    Mar

  • 14

    Mar

  • 28

    May

WPG

Washington Prime

$5.77

(0.00%)

17:49
02/20/19
02/20
17:49
02/20/19
17:49
Earnings
Washington Prime reports Q4 AFFO 38c, one estimate 39c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RMAX

RE/MAX Holdings

$40.54

0.11 (0.27%)

17:48
02/20/19
02/20
17:48
02/20/19
17:48
Hot Stocks
RE/MAX Holdings raises quarterly dividend 5% to 21c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 08

    Mar

  • 13

    Mar

MSA

MSA Safety

$100.06

-1.13 (-1.12%)

17:46
02/20/19
02/20
17:46
02/20/19
17:46
Earnings
MSA Safety reports Q4 adjusted EPS $1.27, consensus $1.27 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TFX

Teleflex

$286.65

4.57 (1.62%)

, PINC

Premier

$38.05

-0.03 (-0.08%)

17:31
02/20/19
02/20
17:31
02/20/19
17:31
Hot Stocks
Teleflex awarded SURPASS deal with Premier »

Teleflex (TFX) has been…

TFX

Teleflex

$286.65

4.57 (1.62%)

PINC

Premier

$38.05

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 03

    Mar

  • 06

    Mar

AGI

Alamos Gold

$4.87

0.05 (1.04%)

17:31
02/20/19
02/20
17:31
02/20/19
17:31
Earnings
Alamos Gold reports Q4 adjusted EPS 1c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NTR

Nutrien

$54.43

1.075 (2.02%)

17:30
02/20/19
02/20
17:30
02/20/19
17:30
Hot Stocks
Nutrien intends to renew share repurchase program »

Nutrien announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 27

    Feb

AKRX

Akorn

$4.03

-0.42 (-9.44%)

, FSNUY

Fresenius SE

$0.00

(0.00%)

17:28
02/20/19
02/20
17:28
02/20/19
17:28
Hot Stocks
Akorn 'strongly contests' Fresenius' proposed amended claims »

Akorn, Inc. (AKRX) said…

AKRX

Akorn

$4.03

-0.42 (-9.44%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 01

    May

MESO

Mesoblast

$4.28

0.13 (3.13%)

17:26
02/20/19
02/20
17:26
02/20/19
17:26
Earnings
Mesoblast reports 1H19 $44.1M loss versus 1H18 profit of $6.7M »

In the first half FY2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

KODK

Kodak

$3.03

-0.045 (-1.47%)

17:21
02/20/19
02/20
17:21
02/20/19
17:21
Hot Stocks
Kodak names Jim Continenza executive chairman »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:20
02/20/19
02/20
17:20
02/20/19
17:20
Hot Stocks
Macquarie Infrastructure sees FY19 EBITDA $610M-$635M vs. $601.9M last year »

Sees FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:19
02/20/19
02/20
17:19
02/20/19
17:19
Earnings
Macquarie Infrastructure reports Q4 adj. EBITDA $152.4M vs. $159.6M last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Hot Stocks
Breaking Hot Stocks news story on Cheesecake Factory »

Cheesecake Factory sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Earnings
Cheesecake Factory sees Q1 adjusted EPS 58c-62c, consensus 61c »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.